Camelot Portfolios’s QuidelOrtho QDEL Stock Holding History

Camelot Portfolios’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,000	Closed	-$28.6K	–	455
2025 Q4	$28.6K	Buy	+1,000	New	+$27.1K	0.02%	351
2024 Q3	–	Sell	-1,000	Closed	-$33.2K	–	458
2024 Q2	$33.2K	Buy	+1,000	New	+$40.9K	0.02%	330
2022 Q2	–	Sell	-2,500	Closed	-$281K	–	238
2022 Q1	$281K	Hold	2,500	–	–	0.14%	182
2021 Q4	$337K	Hold	2,500	–	–	0.14%	184
2021 Q3	$353K	Hold	2,500	–	–	0.18%	151
2021 Q2	$320K	Hold	2,500	–	–	0.13%	187
2021 Q1	$320K	Buy	2,500 +1,000	+67%	+$185K	0.13%	168
2020 Q4	$269K	Hold	1,500	–	–	0.14%	169
2020 Q3	$329K	Hold	1,500	–	–	0.21%	125
2020 Q2	$336K	Buy	+1,500	New	+$235K	0.22%	124

Other funds holding QDEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Camelot Portfolios's QDEL Position: Q1 2026 in Review

Camelot Portfolios sold out of QuidelOrtho (QDEL) in Q1 2026, closing a stake of 1,000 shares — an estimated $28.6K sold.

Camelot Portfolios first reported a position in QDEL in Q2 2020 and held it in 10 quarters. The position peaked at $353K in Q3 2021. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

Camelot Portfolios reported no remaining QuidelOrtho position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 1,000 QuidelOrtho shares in Q1 2026, an estimated $28.6K.
Camelot Portfolios first reported a position in QuidelOrtho in Q2 2020 and held it in 10 quarters.
Camelot Portfolios's QuidelOrtho position peaked at $353K in Q3 2021.
237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.